Purity, disgust, and intent to receive the HPV vaccine

ISRCTN ISRCTN27393344
DOI https://doi.org/10.1186/ISRCTN27393344
Secondary identifying numbers IRB00104624
Submission date
09/01/2019
Registration date
18/01/2019
Last edited
03/09/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
High human papillomavirus (HPV) vaccination rates are key to decreasing the burden of HPV-related diseases. Most messages that promote HPV vaccination to college-aged individuals focus on the long-term consequences of HPV infection. Messages that focus more on short-term consequences of HPV infection may be more effective in this age group. The aim of this study is to see if a message focusing more on the short-term consequences of HPV infection, like genital warts, might increase a person’s intent to receive the HPV vaccine.

Who can participate?
Anyone who is between 18 and 23 years of age, lives in the United States, and has not completed the HPV vaccine series

What does the study involve?
Participation involves completing a short survey (5-10 minutes), viewing of a message with some pictures, and then completing another survey (15-20 minutes). Participants are randomly allocated to view either a message containing an image of a bird on a feeder and a brief description of birdfeeding, or a message containing images of genital warts and a brief description of a Tinder date leading to HPV infection. Intent to receive the HPV vaccine is measured using a survey immediately after the message has been reviewed by the participant.

What are the possible benefits and risks of participating?
The study is not intended to directly benefit participants. The risks in the study are likely to be small. There is a possibility of viewing images of a graphic nature, which some people may find disturbing. There is always a small chance that confidentiality will be broken despite extensive procedures to preserve confidentiality.

Where is the study run from?
The study is being run from Emory University (USA), but all study procedures (questionnaires and messages) take place online.

When is the study starting and how long is it expected to run for?
June 2017 to September 2019 (updated 20/06/2019, previously: June 2019)

Who is funding the study?
Emory University (USA)

Who is the main contact?
Avnika Amin

Contact information

Ms Avnika Amin
Public

1518 Clifton Rd
Atlanta
30322
United States of America

Dr Saad Omer
Scientific

-
New Haven
06520
United States of America

Email saad.omer@yale.edu

Study information

Study designThis interventional study will randomize participants to receive either a visual message related to birdfeeding (control) or a visual message describing the consequences of HPV infection.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Internet/virtual
Study typePrevention
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleHPV, genital warts, and purity: college-aged individuals’ perceptions of HPV and intention to receive the HPV vaccine
Study objectivesParticipants who read the interventional message will have a higher intent to receive HPV vaccine than participants who read the control message.
Ethics approval(s)Emory University Institutional Review Board, 1599 Clifton Road NE, 5th Floor, Atlanta, GA 30322, USA, Tel: +1 (0)404 712 0720, Email: IRB@emory.edu, 11/12/2018, ref: IRB00104624
Health condition(s) or problem(s) studiedIntent to receive HPV vaccine
InterventionParticipants will be randomized using a Qualtrics algorithm. The algorithm randomly presents either the control or experimental visual message while ensuring that control and experimental group numbers are approximately balanced.

This interventional study will randomize participants to receive either:
Control: a visual message containing an image of a bird on a feeder and a brief description of birdfeeding.
Intervention: a visual message containing images of genital warts and a brief description of a Tinder date leading to HPV infection.
Intervention typeBehavioural
Primary outcome measureIntent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. The method of measurement for the primary outcome is a single question asking if the participants intends to initiate (if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses) the HPV vaccine series.
Secondary outcome measuresClicks on a link helping to locate the nearest vaccine clinic, measured using embedded data in the online survey administered immediately after the visual message has been reviewed by the participant.
Overall study start date01/06/2017
Completion date15/09/2019

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants5,049
Key inclusion criteria1. Between 18 and 23 years of age (inclusive)
2. Resident of the United States
3. Has received no more than 2 doses of the HPV vaccine
Key exclusion criteria1. Has completed the HPV vaccine series (3 or more doses)
2. Has already completed the survey
Date of first enrolment15/01/2019
Date of final enrolment15/08/2019

Locations

Countries of recruitment

  • United States of America

Study participating centre

Emory University Rollins School of Public Health
1518 Clifton Rd
Atlanta
30322
United States of America

Sponsor information

Emory University Rollins School of Public Health
University/education

1518 Clifton Rd
Atlanta
30322
United States of America

Website https://www.sph.emory.edu/
ROR logo "ROR" https://ror.org/03czfpz43

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date15/09/2020
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe study protocol, which contains a brief analysis plan, will be made available. Planned publication of the study results in a high-impact, peer-reviewed journal.
IPD sharing planData will be available upon request from Avnika Amin to legitimate researchers with a brief, methodologically sound proposal. This includes de-identified individual participant data used to generate the results reported. The data will be available within one month of publication of the manuscript. After approval, data will be shared via a link (to be provided) and should only be used for the aims detailed in the approved proposals.

Editorial Notes

03/09/2019: The scientific contact's details have been changed.
20/06/2019: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/05/2019 to 15/08/2019.
2. The overall end date was changed from 30/06/2019 to 15/09/2019.
3. The intention to publish date was changed from 30/06/2020 to 15/09/2020.
4. The plain English summary was updated to reflect these changes.